| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 41,305,000 | 36,630,000 | 31,280,000 | 44,904,000 | | Cost of Revenue | 30,074,000 | 27,425,000 | 22,529,000 | 33,451,000 | | | Gross Profit | 11,231,000 | 9,205,000 | 8,751,000 | 11,453,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,632,000 | 4,191,000 | 3,939,000 | 4,617,000 | | Non Recurring | 910,000 | 51,000 | 3,000 | 34,457,000 | | Others | 2,423,000 | 2,455,000 | 2,334,000 | 1,950,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,266,000 | 2,508,000 | 2,475,000 | (29,571,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17,000 | 142,000 | (131,000) | (535,000) | | Earnings Before Interest And Taxes | 3,283,000 | 2,650,000 | 2,344,000 | (30,125,000) | | Interest Expense | 336,000 | 268,000 | 310,000 | 279,000 | | Income Before Tax | 2,947,000 | 2,382,000 | 2,034,000 | (30,404,000) | | Income Tax Expense | 1,427,000 | 1,068,000 | 1,178,000 | 1,360,000 | | Minority Interest |
-
|
-
|
-
| (19,000) | | | | Net Income From Continuing Ops | 3,977,000 | 1,314,000 | 856,000 | (31,764,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,471,000 | 1,314,000 | 856,000 | (31,764,000) | | Preferred Stock And Other Adjustments | 32,000 | (16,000) | (16,000) |
-
| | | Net Income Applicable To Common Shares | $1,503,000 | $1,298,000 | $840,000 | ($31,764,000) |
|
0.34% Nasdaq 0.00%
Income Statement
